- Home
- TLPH vs AFCG Comparison
TLPH vs AFCG Comparison
Compare TLPH & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLPH | AFCG |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 61.4M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TLPH | AFCG |
|---|---|---|
| Price | $1.16 | $3.51 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | ★ 162.7K | 94.8K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 6.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | $2,151,000.00 | ★ $24,563,601.00 |
| Revenue This Year | N/A | $1,334.03 |
| Revenue Next Year | N/A | $17.33 |
| P/E Ratio | ★ N/A | $4.89 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $2.06 |
| 52 Week High | $1.57 | $4.65 |
Technical Indicators
Market Signals| Indicator | TLPH | AFCG |
|---|---|---|
| Relative Strength Index (RSI) | 43.64 | 57.97 |
| Support Level | $1.17 | $2.75 |
| Resistance Level | $1.29 | $3.61 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 18.18 | 49.25 |
Price Performance
Historical ComparisonAbout TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.